Bone Marrow and Stem Cell Transplant research at Penn is accomplished though our NCI approved and funded Hematologic Malignancies Program
Since Penn's discovery of the Philadelphia Chromosome, which revolutionized cancer treatment, we've had a history of groundbreaking research.
Every day our scientists learn more about the causes of hematologic malignancies (leukemia, lymphoma and myeloma) , as well as, better ways to prevent and detect them. Penn continues to be on the cutting edge in the development of new therapies and the use of bone marrow and stem cell transplant to treat these cancers.
All of which can make a difference to patients and their families, both today and in the future.
Shaping the Future of Cancer Care
As one of the nation's largest cancer research centers our investigators benefit each day from collaborations and interactions with over 400 scientists and physicians involved in the Abramson Cancer Center.